Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning
Launched by SHERIEF ABD-ELSALAM · Aug 1, 2020
Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a treatment for people who have been poisoned by aluminum phosphide, a harmful chemical often used in pesticides. The researchers want to see if a procedure called gastric lavage, which involves washing out the stomach with paraffin oil, can help patients who show symptoms of poisoning from this substance. The trial is currently looking for participants and is open to individuals of all ages and genders who are experiencing symptoms after exposure to aluminum phosphide.
To be eligible for this study, patients must be showing signs of acute aluminum phosphide poisoning. However, certain groups cannot participate, including pregnant or breastfeeding women, those who have ingested other harmful substances, and individuals with serious health issues like heart or kidney problems. Participants in the trial can expect to receive the gastric lavage treatment in a controlled medical environment, where their health will be closely monitored. This study aims to find out if this treatment can help improve outcomes for those affected by this serious type of poisoning.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patients with symptomatic acute aluminum phosphide poisoning
- Exclusion Criteria:
- • • Pregnant and lactating women
- • Asymptomatic patients with history of acute aluminum phosphide exposure.
- • Patients with ingestion or exposure to other substances in addition to aluminum phosphide.
- • Patients with other major medical conditions (e.g. cardiovascular disease, renal or hepatic failure).
- • Patients with previous medical intervention (had gastric lavage in any medical center before admission).
- • Patients with disturbed consciousness level
- • Patients with post cardiac arrest cases
About Sherief Abd Elsalam
Sherief Abd-elsalam is a dedicated clinical trial sponsor with extensive expertise in advancing medical research and innovation. Committed to improving patient outcomes, Abd-elsalam oversees the design, implementation, and management of clinical trials across various therapeutic areas. With a strong focus on regulatory compliance and ethical standards, he fosters collaboration between research institutions, healthcare professionals, and regulatory bodies to ensure the successful progression of trials. Abd-elsalam's leadership is characterized by a commitment to scientific integrity and a passion for translating research findings into actionable healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Egypt
Patients applied
Trial Officials
Nadia Ezzat Helal, Ass. Prof.
Principal Investigator
Forensic medicine Department- Tanta University
Ayman Nagy, ass. Prof.
Principal Investigator
Forensic medicine Department- Tanta University
Ghada N. El-Sarnagawy, ass. Prof.
Principal Investigator
Forensic medicine Department- Tanta University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials